Morphological Basis of Pulmonary Edema in Mice with Cytokine-Induced Vascular Leak Syndrome

References

• Rosenberg S A, Lotze M T, Muul L M, Chang A E, Aviis F P, Leitman S, Linehan M, Robertson C N, Lee R E, Rubion J T, Seipp C A, Simpson C G, White D E. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987; 316: 889–897
   PubMed Web of Science ®Google Scholar
• Prui R K, Rosenberg S A. Combined effects of interferon-alpha and interleukin-2 on the induction of a vascular leak syndrome in mice. Cancer Immunol Immunother 1989; 28: 267–274
   PubMed Web of Science ®Google Scholar
• Anderson T D, Hayes T J. Toxicity of human recombinant interleukin-2 in rats. Lab Invest 1989; 60: 331–346
   PubMedGoogle Scholar
• Anderson T D, Hayes T J, Gately M K, Bontempo J M, Stern L L, Truitt G A. Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes. Lab Invest 1988; 59: 598–612
   PubMed Web of Science ®Google Scholar
• Goldblum S E, Yoneda K, Cohen D A, McClain C J. Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1β. Infect Immun 1988; 56: 2255–2263
   PubMed Web of Science ®Google Scholar
• Rosenstein M, Ettinghausen S, Rosenberg S. Extravasation of intravascular fluid by the systemic administration of recombinant interleukin-2. J Immunol 1986; 137: 1735–1742
   PubMed Web of Science ®Google Scholar
• Ettinghausen S E, Prui R K, Rosenberg S A. Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. J Natl Cancer Inst 1988; 80: 177–188
   PubMed Web of Science ®Google Scholar
• Peace D J, Cheever M A. Toxicity and therapeutic efficacy of the high-dose interleukin-2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia. J Exp Med 1989; 169: 161–173
   PubMed Web of Science ®Google Scholar
• Gately M K, Anderson T D, Hayes T J. Role of asialo-GM-positive lymphoid cells in mediating the toxic effects of recombinant IL-2 in mice. J Immunol 1989; 141: 189–200
   Web of Science ®Google Scholar
• Cotran R S, Pober J S, Gimbrone M A, Springer T A, Wiebke E A, Gaspari A A, Rosenberg S A, Lotze M R. Endothelial activation during interleukin-2 immunotherapy: A possible mechanism for the vascular leak syndrome. J Immunol 1987; 140: 1883–1888
   Web of Science ®Google Scholar
• Munro J M, Pober J S, Cotran R S. Tumor necrosis factor and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio Anubis. Am J Pathol 1989; 135: 121–133
   PubMed Web of Science ®Google Scholar
• Quesada J R, Tolpaz M, Rios A, Kurzrock R, Gutterman J U. Clinical toxicity of interferons in cancer patients: A review. J Clin Oncol 1986; 4: 234–243
   PubMed Web of Science ®Google Scholar
• Averbuch S D, Austin H A, Sherwin S A, Antonovych T, Bunn P A, Longo D L. Acute interstitial nephritis with nephrotic syndrome following recombinant leukocyte A interferon therapy for mycosis fungoides. N Engl J Med 1984; 310: 32–35
   PubMed Web of Science ®Google Scholar
• Cotran R S, Pober J S. Effects of cytokines on vascular endothelium: Their role in vascular and immune injury. Kidney Int 1989; 35: 969–975
   PubMed Web of Science ®Google Scholar
• Morel-Maroger L. Glomerular lesions induced by interferon. Transplant Proc 1982; 14: 499–508
   PubMed Web of Science ®Google Scholar
• Pober J S. Cytokine-mediated activation of vascular endothelium. Am J Pathol 1988; 133: 426–433
   PubMed Web of Science ®Google Scholar
• Averbrook B J, Yamamoto R S, Ulich T R, Jeffes E W, Masunaka I, Granger G A. Purified native and recombinant alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin. J Clin Immunol 1987; 7: 333–340
   PubMed Web of Science ®Google Scholar
• Cybulsky M L, Colditz I G, Movat H Z. The role of interleukin-1 in neutrophil leukocyte emigration induced by endotoxin. Am J Pathol 1986; 124: 367–372
   PubMed Web of Science ®Google Scholar
• Issekutz T B, Stoltz J M, van der Meide P. Lymphocyte recruitment in delayed hypersensitivity: The role of IFN-γ. J Immunol 1988; 140: 2989–2993
   PubMed Web of Science ®Google Scholar
• Movat H Z, Burrowes C E, Cybulsky M L, Dinarello C A. Acute inflammation and a Schwartzman-like reaction induced by interleukin 1 and tumor necrosis factor: Synergistic action of the cytokines in the induction of inflammation and microvascular injury. Am J Pathol 1987; 129: 463–476
   PubMed Web of Science ®Google Scholar
• Rosenbaum J T, Howes E L, Rubin R M, Samples J R. Ocular inflammatory effects of intravitreally injected tumor necrosis factor. Am J Pathol 1988; 133: 47–53
   PubMed Web of Science ®Google Scholar
• Wankowicz Z, Megyeri P, Issekutz A. Synergy between tumor necrosis factor and interleukin-1 in the induction of polymorphonuclear leukocyte migration during inflammation. J Leukocyte Biol 1988; 43: 349–356
   PubMed Web of Science ®Google Scholar
• Roder J C. The beige mutation in the mouse, I: A stem cell predetermined impairment in natural killer cell function. J Immunol 1979; 123: 2168–2173
   PubMed Web of Science ®Google Scholar
• Roder J C, Lohmann-Matthes M-L, Domzig W, Wigzell H. The beige mutation in the mouse, II: Selectivity of the natural killer (NK) cell defect. J Immunol 1979; 123: 2174–2181
   PubMed Web of Science ®Google Scholar
• Saxena R K, Saxena Q B, Alder W H. Defective T-cell response in beige mutant mice. Nature (London) 1982; 295: 240–241
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Wood H, Swart R T. Lysosomal elastase and cathepsin G in beige mice. J Exp Med 1986; 163: 665–677
   PubMed Web of Science ®Google Scholar
• Rosenberg S A, Grim E Q, McGrogan M, Doyle M, Kawasaki E, Koths K, Mark D F. Biological activity of human recombinant interleukin-2 produced in Escherichia coli. Science 1984; 223: 1412–1415
   PubMed Web of Science ®Google Scholar
• Brunda M J, Rosenbaum D. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons. Cancer Res 1984; 44: 597–601
   Google Scholar
• Rehberg E, Kelder B, Hoal E G, Pestka S. Specific molecular activities of recombinant and hybrid leukocyte interferon subtypes. J Biol Chem 1982; 257: 11497–11502
   PubMed Web of Science ®Google Scholar
• Camussi G, Salvidio G, Niesen N, Brentjens J R, Andres G. Effect of chlorpromazine on the development of experimental glomerulonephritis and Arthus reaction. Am J Pathol 1988; 131: 418–434
   PubMed Web of Science ®Google Scholar
• Anderson T D, Valentine T, Lucas D, Becker J, Durham S K, Gatley M K, Hayes T J. Interleukin-2 induced vascular leak syndrome in mice is secondary to endothelial cytotoxicity mediated by lymphokine activated killer (LAK) cells. Lab Invest 1989; 60(12)3A
   Google Scholar
• Damle N K, Doyle L V. IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. J Immunol 1989; 142: 2660–2669
   PubMed Web of Science ®Google Scholar
• Cotran R S. New roles for endothelium in inflammation and immunity. Am J Pathol 1987; 129: 407–413
   PubMed Web of Science ®Google Scholar
• Hook G R, Greenwood M A, Barba D, Ikejiri B, Chen S N, Oldfiled E H, Weber R J, Muul L M. Morphology of interleukin-2 stimulated human peripheral blood mononuclear effector cell killing glioma-derived tumor cells in vitro. J Natl Cancer Inst 1988; 80: 171–177
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Perussia B. Biology of disease: Human natural killer cells: biologic and pathologic aspects. Lab Invest 1984; 50: 489–513
   PubMed Web of Science ®Google Scholar
• Andres G, Cerra F, Elti G, Cortesini R, Casciani C, Hsu K C. Lymphocyte and blast cell glomerulonephritis in renal allografts of rats injected with phytohe-magglutinin. Cell Immunol 1974; 13: 146–163
   PubMed Web of Science ®Google Scholar
• Willms-Kretschmer K, Flax M H, Cotran R S. The fine structure of the vascular response in hapten-specific delayed hypersensitivity and contact dermatitis. Lab Invest 1967; 17: 334–349
   PubMed Web of Science ®Google Scholar
• Aronson F R, Libby P, Brandon E P, Janicke M W, Mier J W. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells: A potential mechanism for endothelial injury. J Immunol 1988; 141: 158–163
   PubMed Web of Science ®Google Scholar
• Damle N K, Doyle L V, Bender J R, Bradly E C. Interleukin-2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J Immunol 1987; 138: 1779–1785
   PubMed Web of Science ®Google Scholar
• Bevilacqua M P, Pober J S, Mendrick D L, Cotran R S, Gimbrone M A, Jr. Identification of an inducible endothelial leukocyte adhesion molecule ELAM-1. Proc Natl Acad Sci 1987; 84: 9238–9242
   PubMed Web of Science ®Google Scholar
• Pober J S, Bevilacqua M P, Mendrick D L, Lapierre L A, Fiers W, Gimbrone M A, Jr. Two distinct monokines, interleukin-1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986; 136: 1680–1687
   PubMed Web of Science ®Google Scholar
• Brunda M J, Tarnowski D, Davatelis V. Interaction of recombinant interferons with recombinant interleukin-2: Differential effects on natural killer cell activity and interleukin-2 activated killer cells. Int J Cancer 1986; 37: 787–793
   PubMed Web of Science ®Google Scholar
• Madara J L, Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989; 83: 724–727
   PubMed Web of Science ®Google Scholar
• Stolpen A H, Guinan E C, Fiers W, Pober J S. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol 1986; 123: 16–24
   PubMed Web of Science ®Google Scholar
• Moss J, Shore I, Woodrow D, Gresser I. Interferon-induced glomerular basement membrane and endothelial cell lesions in mice. Am J Pathol 1988; 133: 557–563
   PubMed Web of Science ®Google Scholar
• Selby P, Kohn J, Raymond J, Judson J, McElwain T. Nephrotic syndrome during treatment with interferon. Br Med J 1985; 290: 1180
   PubMed Web of Science ®Google Scholar
• Thijs L G, Hack E C, Strack Van Schijndel R JM, Nuijens J, II, Wolbink G J, Eerenberg-Belmer A JM, Van der Vall H, Wagstaff J. Activation of the complement system during immunotherapy with recombinant IL-2. J Immunol 1990; 144: 2419–2424
   PubMed Web of Science ®Google Scholar
• Warren J S, Kunkel S L, Cunningham T W, Johnson K J, Ward P A. Macrophagederived cytokines amplify immune complex-triggered O2 responses by rat alveolar macrophages. Am J Pathol 1988; 130: 489–495
   PubMed Web of Science ®Google Scholar